Summary
Capricor officials said the company was prepared for the meeting and does not expect it to delay the FDAs decision on the therapy.
Source: Managed Healthcare Executive
Exclusive AI-Powered News Insights (For Members only)
Disclaimer:This content is AI-generated from various trusted sources and is intended for informational purposes only. While we strive for accuracy, we encourage you to verify details independently. Use the contact button to share feedback on any inaccuracies—your input helps us improve!
